Combined Authority Business Board appoints five members
The Business Board has been strengthened with the appointment of five private sector members with a wide range of experience and expertise.
The Paradigm Shift: Navigating the emergence of value-based contracts for future gene therapies
Value-based contracting (VBC) has been difficult to execute in the pharmaceutical arena, especially in the gene therapy space.
3 Steps for cell & gene therapy medical affairs teams to provide strategic value
A phrase often recited within the pharmaceutical and biotechnology industries in recent years is that medical affairs is the third strategic pillar of success, along with R&D and commercial.
The Paradigm Shift: Navigating the emergence of value-based contracts for future gene therapies
Value-based contracting (VBC) has been difficult to execute in the pharmaceutical arena, especially in the gene therapy space.
Template library - a feature spotlight from Doc2
Doc2 writes...We’re thrilled to announce the arrival of a game-changing new feature within Doc2: the template library! This latest enhancement is all about streamlining the contract creation process even further, providing a robust solution for those who need to distribute their templates easily and compliantly.
High accuracy sample positioner now offers up to 800 µm travel
Queensgate’s NanoScan SP800 nanopositioning sample scanner offers high-accuracy positioning performance for longer ranges.
Glox Therapeutics secures £4.3M seed funding to develop precision antimicrobials targeting drug-resistant bacteria
Glox Therapeutics Secures £4.3M Seed Funding to Develop Precision Antimicrobials Targeting Drug-resistant Bacteria
Cambridge Intelligence boosts analysis at Italy’s central bank
Together with our partners at Sistemi & Automazione, we’ve secured a tender to provide Italy’s central with advanced link analysis capability, powered by our KeyLines data visualization toolkit.
Prediabetes: tips for preventing diabetes and improving health
14 of November is World Diabetes Day. It is estimated that 422 million people around the world are living with diabetes.
Invisible hearing aids “a first for Cambridgeshire”
Discover the future of hearing care at angli-EAR Hearing in Great Shelford. We're proud to be the first audiology clinic in Cambridgeshire offering Phonak Lyric, a revolutionary 100% invisible hearing aid. Unlike traditional devices, Lyric sits deep inside the ear canal for complete invisibility, worn 24/7 for months. Lead Audiologist Trevor Chapman explains the benefits, including relief from…
1 in 10 go free in November at Hilton Cambridge City Centre
PLANNING YOUR LAST MEETING FOR THE YEAR? 1 IN 10 GO FREE IN NOVEMBER AS OUR GIFT TO YOU
A longitudinal perspective on innovation
There is growing interest in the innovation process in the biopharmaceutical industry, with particular public scrutiny around the composition of research and development (R&D) spending and the role of intellectual property.
Social impact organisations across Cambridgeshire & Peterborough supported by new Allia-led project
Allia is leading a new project to help social impact organisations across Cambridgeshire and Peterborough so that they can build resilience, grow and create more positive change.
kdm communications wins Marketing Agency of the Year 2023
kdm communications is proud to be named the Marketing Agency of the Year 2023 by the Business Intelligence Group, as part of the 2023 Public Relations and Marketing Excellence Awards. This accolade recognises the organisation's outstanding reputation as a leading life sciences marketing agency, delivering quantifiable business results for its clients across the world.
Marginal gains – The pursuit of perfect design
Flynn Product Design writes...In the industrial design space, the pursuit of achieving perfect design is never-ending. Often when people are looking to solve a problem or improve their work, they seek a single transformative solution to address all the issues.
Government announces changes to holiday pay, TUPE and Working Time Regulations
HR Dept. writes...Good news for small and medium-sized businesses. The Government announces changes to holiday pay, TUPE and Working Time Regulations.
Expand your horizons: think big with a Cleanroom Solutions turnkey project
Let the Guardtech Group heritage business take away the hassle of building the large-scale facility of your dreams
New health technology will protect self-driving car manufacturers
electronRx Limited writes...
NanoSyrinx appoints Anthony Johnson as Non-Executive Director
Appointment of Big Pharma executive strengthens leadership team to drive ambitious growth strategy
Extreme events driving innovation in agri-tech, REAP conference reveals
The NFU Vice-President, David Exwood, and Defra’s Chief Scientific Adviser, Professor Gideon Henderson, were the keynote speakers at Agri-TechE’s REAP Conference 2023, which also saw presentations from early-stage companies that are addressing increasingly urgent real-world problems from a different perspective.
Visualising public speaking success
Simon Hall writes...If you’ve got a big presentation to give, this trick can help to make sure you smash it...
Get to know the Governance and Ethics team at the NIHR BioResource
Who are they, what a day looks like in the team and everything involved in making our Governance and Ethics team one of the key resources as part of the NIHR BioResource!
Snakes and Ladders - navigating your investment journey
A workshop for tech founders and directors who are new to the investment journey.
How to build vital space for recovery into your change plans
It’s vital that we have space to recover during and after significant events and project and programme milestones. This space can help us regroup, learn and stay galvanised for whatever the next steps might be.
Oncology vaccines: Are they positioned for PMA success?
With combinations taking center stage following the initial influx of immune checkpoint inhibitor monotherapies, the authors look ahead to the potential of mRNA vaccines in oncology and describe the pricing and market access opportunities and challenges that may await current and future competito